INDV.NASDAQIndivior PLC

Form 4: Indivior Director Receives Stock Grant

Sentiment:

Insider Transaction


Indivior Pharmaceuticals, Inc. reports a stock grant to Director Stuart A. Kingsley, involving 6,518 Restricted Stock Units.

Summary

  • Stuart A. Kingsley, a Director at Indivior Pharmaceuticals, Inc., received a grant of 6,518 Restricted Stock Units (RSUs) on May 13, 2026.
  • These RSUs represent a contingent right to receive one share of the Issuer's common stock.
  • The RSUs are set to vest on the day immediately preceding the date of the annual stockholders' meeting following the grant date, contingent upon Kingsley's continued service.
  • Following this transaction, Kingsley beneficially owns 12,100 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard compensation grant to a director rather than a significant strategic or financial development.

Positives

  • Director Stuart A. Kingsley received a significant grant of 6,518 Restricted Stock Units, indicating continued investment in the company's future by its leadership.
  • The grant vests based on continued service, aligning the director's incentives with the company's long-term performance.

Future Outlook

The vesting of the RSUs is contingent on continued service and is tied to the date of the annual stockholders' meeting, suggesting a forward-looking incentive structure.

Industry Context

StockSavvy.ai notes that grants of Restricted Stock Units to directors are a common practice in the pharmaceutical industry to align executive compensation with long-term company performance and shareholder value.

Stakeholder Impact

  • Shareholders: The grant aligns director incentives with long-term company performance, potentially benefiting shareholders through improved governance and strategic execution.

Next Steps

  • The RSUs will vest on the day immediately preceding the date of the annual stockholders' meeting following the grant date, subject to continued service.

Key Dates

DateDescription
05/13/2026Date of transaction (grant of RSUs)
05/14/2026Date of filing signature

Keywords

Indivior Pharmaceuticals, INDV, Form 4, Insider Trading, Stock Grant, Restricted Stock Units, RSU, Director Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.